Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Pathol ; 65(7): 635-7, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22461649

RESUMO

AIMS: An external positive control section is included in each immunohistochemical analysis as a well recognised and validated technique for standardising results. The method is time-consuming and expensive. On the contrary, internal controls are warranted and inexpensive, but their use is only feasible in selected diagnoses. The aim of this work is to show how the method of the authors allows improving the interpretation and cuts costs in the immunohistochemical analysis of bone marrow specimens. METHODS: A paraffin-embedded tonsil tissue cylinder was sampled from a donor block using an automated sampler and included as an 'internal control' together with a bone marrow biopsy in a recipient block, avoiding the use of external tonsil tissue control. To validate this technique, the authors compared the quality of immunohistochemistry, the workload and costs with routine external control in 50 consecutive bone marrow biopsies. RESULTS: Processing simultaneously the sample and the tissue control in the same block, 60 external positive control tests were spared. Only a few minutes were taken for the preparation of the recipient blocks, and no particular technical skill was required. Considering that the volume of antibodies used for the analysis of each sample was not increased, a considerable amount of the disposable material was saved. The workload of technicians was decreased and some potential technical bias was avoided. The time required for pathologists to interpret the slides was also reduced. CONCLUSIONS: In conclusion, this seems to be a feasible, cost-cutting and quality-improving technique, not limited to haematopathology but potentially extensible to other fields of pathology.


Assuntos
Imuno-Histoquímica/métodos , Imuno-Histoquímica/normas , Controle de Qualidade , Análise Serial de Tecidos/métodos , Análise Serial de Tecidos/normas , Biópsia , Medula Óssea/patologia , Controle de Custos , Estudos de Viabilidade , Humanos , Imuno-Histoquímica/economia , Inclusão em Parafina , Reprodutibilidade dos Testes , Manejo de Espécimes , Análise Serial de Tecidos/economia
2.
J Cutan Pathol ; 36(6): 637-46, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19515042

RESUMO

BACKGROUND: Nucleolin is a major nucleolar argyrophilic protein involved in carcinogenesis. There are only few studies on its tissue expression in human cancer and none in melanoma. We aimed at exploring this protein and its prognostic impact in cutaneous melanocytic lesions. METHODS: We studied 193 cases including benign, dysplastic and malignant melanocytic lesions. Nuclear positivity was evaluated by immunohistochemistry and quantified by automated image analysis. RESULTS: Most dysplastic and malignant lesions showed high percentages of cells with abnormal patterns of nuclear positivity (Abn+N) consisting in multiple, irregular, positive dots (ID+) and a coarse, irregularly positive nucleoplasm (CNpl+) or both (ID+CNpl+). The patterns CNpl+ and/or ID+CNpl+ were never observed in benign lesions, in which ID+ were also virtually absent. Abn+N% was significantly lower in dysplastic nevi than in primary melanomas and metastases and in primary melanomas than in metastases (p < 0.05). Furthermore, Abn+N was the second powerful prognostic discriminator, after melanoma thickness, and a significantly lower survival was observed in vertical growth phase melanoma patients showing Abn+N in more than 50% of melanoma cells. CONCLUSION: An altered nuclear nucleolin expression seems to accompany melanoma progression. Further investigation on nucleolin functionality and subcellular trafficking could add information on its altered role in melanoma.


Assuntos
Melanoma/metabolismo , Melanoma/patologia , Fosfoproteínas/biossíntese , Proteínas de Ligação a RNA/biossíntese , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia , Biomarcadores Tumorais/análise , Núcleo Celular/metabolismo , Progressão da Doença , Síndrome do Nevo Displásico/metabolismo , Síndrome do Nevo Displásico/patologia , Humanos , Interpretação de Imagem Assistida por Computador , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Melanoma/mortalidade , Fosfoproteínas/genética , Lesões Pré-Cancerosas/patologia , Prognóstico , Proteínas de Ligação a RNA/genética , Neoplasias Cutâneas/mortalidade , Nucleolina
3.
Muscle Nerve ; 27(3): 370-3, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12635125

RESUMO

Nerve growth factor (NGF) is a neurotrophin that is expressed during muscle development and is also capable of favoring muscle regeneration in experimental studies. The presence of NGF in muscular dystrophies, such as Duchenne and Becker muscular dystrophies, has never been fully explored. By means of immunohistochemistry, we show that regenerating muscle fibers from such patients consistently express NGF, as do myofibroblasts and mast cells. By contrast, rest fibers from dystrophic patients, as well as muscle fibers from healthy, control patients and even regenerative muscle fibers in polymyositis do not show NGF immunoreactivity. The paracrine effect of NGF on muscle regeneration, as well as its chemoattractant capacities for mast cells, may contribute to explaining why regenerating fibers most frequently occur in clusters and why mast cells are more numerous in dystrophic muscles. Moreover, being a mediator of wound healing and tissue fibrosis, NGF may contribute to long-term muscle regeneration impairment by tissue fibrosis in the muscular dystrophies.


Assuntos
Músculo Esquelético/química , Distrofia Muscular de Duchenne/patologia , Fator de Crescimento Neural/análise , Biópsia , Pré-Escolar , Humanos , Imuno-Histoquímica , Lactente , Músculo Esquelético/patologia , Músculo Esquelético/fisiologia , Regeneração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...